The presence of periodontal disease in chronic kidney disease significantly increased the risk of all-cause, but not cardiovascular, mortality.
Nonsmokers exposed to secondhand cigarette smoke are at increased risk of chronic kidney disease (CKD), according to new study findings published in the Clinical Journal of the American Society of Nephrology. The study included 131,196 never-smokers with normal kidney function who participated in the Korean Genome and Epidemiology Study from 2001 to 2014 (mean age…
Patients with stage 3 or higher chronic kidney disease (CKD) have modestly increased risks of cancer, including prostate cancer in men, compared with patients who have normal kidney function, Hong Xu, MD, PhD, of Karolinska Institutet in Stockholm, and colleagues reported in the Clinical Journal of the American Society of Nephrology. Among 719,033 Swedes aged…
Kidney disease is a global public health problem, affecting over 750 million persons worldwide.1,2 The burden of kidney disease varies substantially across the world, as does its detection and treatment. In many settings, rates of kidney disease and the provision of its care are defined by socio-economic, cultural and political factors leading to significant disparities.3 World Kidney…
Rates of serum creatinine events were higher among patients treated with both lesinurad and a xanthine oxidase inhibitor.
Patients treated with the mineralocorticoid receptor antagonist had a higher frequency of moderate hyperkalemia compared with placebo recipients.
In a new study, patients with serum phosphate levels above 1.78 mmol/L at the start of peritoneal dialysis had a nearly 2-fold increased risk of death.
In a study, CKD patients with OSA treated with nasal continuous positive airway pressure (CPAP) had significantly higher eGFR after 12 months of treatment than those not receiving CPAP.
Proliferative vs non-proliferative diabetic retinopathy in CKD patients is associated with a higher risk of CKD progression.
Laboratory testing for parathyroid hormone, phosphorus, 25-hydroxyvitamin D, and other biochemical markers of mineral bone disease falls short of 2012 KDIGO guidelines.